The drug adaptaquin blocks ATF4/CHOP-dependent pro-death Trib3 induction and protects in cellular and mouse models of Parkinson's disease

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (R01-NS072050, P01 NIA AG014930)
  • Parkinson's Disease Foundation
  • Sperling Center for Hemorrhagic Stroke Recovery at Burke Neurological Institute
  • Burke Foundation
  • Dr. Miriam and Sheldon G Adelson Medical Research Foundation

This publication has 50 references indexed in Scilit: